AMY COBB: Open Payments
NPI 1144209081 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 33 payments from 14 companies in 2025. Trend: 2023 $668 · 2024 $720 · 2025 $590
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $118 |
| Novo Nordisk Inc | 4 | $68 |
| ABBVIE INC. | 4 | $57 |
| SANOFI-AVENTIS U.S. LLC | 3 | $56 |
| Tris Pharma Inc | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: HETLIOZ, LEQVIO, TZIELD, VRAYLAR, Ozempic, FANAPT, Dyanavel XR, Heplisav-B.
Industry payments across KY — which companies pay providers there.
